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Summary
The N gene product of coliphage k, with a number of
host proteins (Nus factors), regulates phage gene
expression by modifying RNA polymerase to a form
that overrides transcription-termination signals.
Mutations in host nus genes diminish this N-mediated
antitermination. Here, we report the isolation and
characterization of the rpoAD305E mutation, a single
amino acid change in the carboxy terminal domain
(CTD) of the a subunit of RNA polymerase, that
enhances N-mediated antitermination. A deletion of
the 3 ' terminus of rpoA , resulting in the expression
of an a subunit missing the CTD, also enhances N-
mediated antitermination and, similar to rpoAD305E ,
suppresses the effect of nus mutations. Thus, the N–
Nus complex may be affected through contacts with
the CTD of the a subunit of RNA polymerase, as is a
group of regulatory proteins that influences initiation
of transcription. What distinguishes our findings on
the N–Nus complex from those of previous studies
with transcription proteins is that all of the regulators
characterized in those studies bind DNA and influ-
ence transcription initiation; whereas the N–Nus
complex binds RNA and affects transcription elonga-
tion. A screen of some previously identified rpoA
mutations that influence transcription activators
revealed only one other amino acid change, L290H, in
the CTD of the a subunit , that influences antitermina-
tion. Although our results provide evidence that inter-
actions of the a subunit of RNA polymerase must be
considered in forming models of transcription anti-
termination, they do not provide information as to
whether the interactions of a that ultimately influence
antitermination occur during initiation or during elon-
gation of transcription.
Introduction
Programmed regulation of transcription termination is one
strategy for control of gene expression that is employed by
a wide variety of organisms (Das, 1993). This modulated
readthrough of transcription-termination signals, called
transcription antitermination, was originally postulated to
explain the activation of coliphage l delayed-early genes
by the phage-encoded N gene product (Roberts, 1969).
Genetic studies of this antitermination process have iden-
tified a set of Escherichia coli genes, nus, whose protein
products are required for effective N-mediated antitermi-
nation (Friedman et al., 1984a). Some of these Nus pro-
teins serve as transcription-elongation factors for E. coli
(reviewed by Yager and Von Hippel, 1987) and all are
essential for host viability (Friedman and Court, 1995).
The participation of a large number of proteins in anti-
termination raises the obvious question of how the
members of such a collection of host and viral proteins
interact with each other and, importantly, how the complex
itself interacts with RNA polymerase (RNP) to create a
termination-resistant transcription complex (Das, 1992;
1993; Friedman, 1988; Roberts, 1992; 1993; Greenblatt
et al., 1993).
Central to N-mediated modification of RNA polymerase
are the nut signals (Rosenberg et al., 1978; Salstrom and
Szybalski, 1978a). Located downstream of the early l pro-
moters, pL and pR, the nut sites direct the assembly of the
antitermination complex. Transcripts initiating at pL and
pR are partially terminated at Rho-dependent terminators
tL1 and tR1, respectively (see Fig. 1) (Roberts, 1969; Sal-
strom and Szybalski, 1978b). The resulting short pL
transcript includes the message of the N gene, whose
product, N, acts with the host Nus proteins at the NUT
RNA signals (Rosenberg et al., 1978; Somasekhar et al.,
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1982; Lazinski et al., 1989; Salstrom and Szybalski,
1978a,b; Barik et al., 1987; Olson et al., 1982; 1984;
Warren and Das, 1984; Zuber et al., 1987; Nodwell and
Greenblatt, 1991; Friedman et al., 1990; 1984a) to modify
the transcribing RNA polymerase. The nut regions have
been divided by sequence homologies, as well as by
function, into two components (Friedman and Olson,
1983; Olson et al., 1984; Hasan and Szybalski, 1986;
Lazinski et al., 1989). The BOX-A component appears to
be the recognition site for the NusB and possibly the
S10 (NusE) proteins (Friedman et al., 1990; Nodwell and
Greenblatt, 1993; Patterson et al., 1994) and an inhibitory
host factor whose existence has been inferred from results
of genetic and physiological studies (Patterson et al., 1994).
The BOX-B component, a region of hyphenated dyad
symmetry that forms a hairpin, has been identified as
the recognition site for N and NusA (Doelling and Franklin,
1989; Lazinski et al., 1989; Das, 1992; Chattopadhyay et
al., 1995; Mogridge et al., 1995). (Note that the following
convention is being followed in labelling nucleic acid
sites: the DNA site will be in lower-case italics and the
RNA site will be capitalized, e.g. the DNA will be referred
to as ‘nut ’, while the RNA will be referred to as ‘NUT’.)
Most of the Nus factors were identified by mutations that
influence the effectiveness of the N-mediated antitermina-
tion process without affecting host viability. Subsequent in
vitro studies confirmed the essential roles of these pro-
ducts in this antitermination process (Das and Wolska,
1984; Horwitz et al., 1987). Two types of mutations were
employed in those studies. The first are mutations that
cause a failure in N-mediated antitermination at higher
temperatures, a phenotype we shall refer to as Nus7 (N
undersupplied). Two of these mutations, nusA1 at
minute 69 and nusB5 at minute 11 on the E. coli chromo-
some, are located in genes that had not previously been
identified and thus were defined by their antitermination
defect. Three are in genes that were of known function:
rpsJ/nusE, encodes ribosomal protein S10 and is located
at minute 72; rho/nusD, encodes the Rho transcrip-
tion-termination protein and is located at minute 90; and
rpoB, encodes the b subunit of RNA polymerase and is
located at minute 85 (reviewed in: Friedman et al.,
1984a; Das, 1992; Greenblatt et al., 1993; Friedman,
1992). Hosts with any of these nus mutations have a
reduced ability to support l growth, solely because of a
defect in N-mediated antitermination.
The other type of mutations used to identify host factors
involved in N action are second-site suppressors that were
isolated on the basis of restoring N antitermination activity
in the presence of nusA1. Second-site suppressor muta-
tions of this type were identified as rif r mutations in the
rpoB gene (Sparkowski and Das, 1992; Jin et al., 1988),
the nusB101 mutation (Ward et al., 1983; Court et al.,
1995) and the nusG4 mutation in a previously unidentified
gene (Downing et al., 1990). In vitro studies provided evi-
dence that NusG is a component of the N-antitermination
complex (Li et al., 1992). However, its role in antitermi-
nation has not been definitively established, because
depleting NusG in the cell does not result in reduced anti-
termination (Sullivan and Gottesman, 1992). Although
other phenotypes associated with mutations in nus genes
have been identified (Tsugawa et al., 1988; Ward et al.,
1983; Kur et al., 1989; Kuroki et al., 1982; Miyashita et
al., 1982; Ward and Gottesman, 1981; Zheng and Fried-
man, 1994; Court et al., 1995), this discussion will be
limited to those mutations that influence N action by caus-
ing or suppressing a Nus7 phenotype.
The nusB101 and nusG4 mutations also suppress the
Nus7 phenotype imposed by the nusE71 mutation (Ward
et al., 1983; Sullivan et al., 1992). Mutations identified in l
that exhibit similar suppression of the nusA1 and nusE71
mutations have been located in the nutR–boxA sequence
(Friedman et al., 1990) and in the N gene (Schauer et al.,
1987; Franklin, 1985). These mutations were initially
selected because they fostered l growth in E. coli nusA1
mutants, but they subsequently were also shown to foster
l growth in E. coli nusE71 mutants (Schauer et al., 1987;
Friedman and Olson, 1983). With the exception of
nusB101, which was not tested for the obvious reason
that it is a nusB mutation, all of these suppressors, bacterial
as well as phage, show relatively poor suppression of the
Nus7 phenotype conferred by the nusB5 mutation
(Schauer et al., 1987; Ward et al., 1983). It has been sug-
gested that suppressor mutations that alter a component
of the N–Nus complex suppress because they enhance
(one or more) interactions in the complex, compensating
for a suboptimal interaction caused by the primary nus
mutation (Schauer and Friedman, 1985; Das, 1992).
We report that mutations in the rpoA gene also suppress
defective N–Nus-mediated transcription antitermination
# 1996 Blackwell Science Ltd, Molecular Microbiology, 21, 839–851
Fig. 1. Schematic genetic map of the early transcribed region of
the l genome. The positions of representative genes are indicated
above the bold line, with an expansion of the nutR site showing the
relative positions of boxA and boxB. The nutL site is positioned
downstream of pL in the opposite orientation to nutR. Below the
line are shown the positions of sequences containing signals
(promoters, nut sites, and terminators). Lower part of the figure
shows the nature of transcription in the absence and presence of
effective N–Nus complexes.
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caused by nus mutations. These rpoA mutations change
amino acids within a small segment of the carboxy term-
inal domain (CTD) of the a subunit of RNA polymerase,
indicating that a distinct molecular surface may contribute
to the control of the activity of the N–Nus complex.
Results
Selection of rpoAD305E, a second-site suppressor of
nusE71
The rpoAD305E mutation, originally called sneA16 (Fried-
man, 1988; Schauer, 1985; Schauer and Friedman, 1985),
was isolated by selecting for second-site mutations that
suppress the Nus7 phenotype of an E. coli strain carrying
the nusE71 mutation. The selection was essentially that
devised by Ward et al. (1983). The E. coli strain (K1953)
used in the selection carries the nusE71 mutation and
has the gal operon under the control of the l pL promoter
(Fig. 2). Because of intervening transcription terminators,
expression of gal genes is entirely dependent on N-
mediated transcription antitermination. Even though N is
expressed, the strain is Gal7, because the nusE71 muta-
tion does not support N action. Thus, suppression of this
nusE71 defect would result in a Gal+ phenotype. We
attempted to direct the mutagenesis to the 72 min region
using P1 transduction for localized mutagenesis (see the
Experimental procedures). This region of the E. coli
chromosome was chosen as a possible location of sup-
pressor mutations, because it is rich in genes encoding
ribosomal proteins. We postulated that if one or more ribo-
somal proteins interacted with S10 during antitermination,
a mutation in one of the genes encoding such a protein
might suppress the effect of the nusE71 mutation. The
marker selected in the transduction was a Tn10 trans-
poson, zhb-3082::Tn10, located in this region.
The rpoAD305E mutation, obtained from this selection,
was located on the E. coli genetic map using standard
genetic techniques (Miller, 1972; Sternberg and Maurer,
1991). These manipulations located the rpoAD305E
mutation, as expected, in the 72 min region of the E. coli
chromosome, and finer mapping studies suggested that
the mutation is in or closely linked to the rpoA gene,
which encodes the a subunit of RNA polymerase.
Complementation analysis and marker rescue
The dominance of the rpoAD305E mutation was charac-
terized using a strain with the rpoAD305E allele on the
chromosome. The effectiveness of N action could be
assessed because the bacterium carries the pL–gal
fusion described above and also in Fig. 2. The bac-
terium, E. coli K6325, carries, in addition to the fusion,
the nusE71 mutation that normally blocks N action, but
because K6325 also carries the rpoAD305E mutation,
this blockage of N action is suppressed. The gal operon
can be expressed allowing K6325 to metabolize galactose
and thus to form red colonies on a MacConkey–galactose
plate at 408C. A derivative of K6325 containing pNO2530
(a plasmid with the wild-type rpoA and rplQ genes down-
stream of plac) (Bedwell and Nomura, 1986) forms pink
colonies, reflecting a reduction in gal operon expression
and thus a reduced suppressor phenotype. Note that
under these conditions K1953, the starting nusE71 deriva-
tive, forms white colonies (low gal-operon expression) and
K1947, the nus+ derivative, forms red colonies (high gal-
operon expression). Thus, by this assay, rpoA+ expressed
from the pNO2530 plasmid is only partially dominant to
the single chromosomal copy of the rpoAD305E allele.
A plasmid with the rpoAD305E allele was obtained from
K6325 carrying pNO2530 by identifying rare red colonies
on MacConkey–galactose plates containing ampicillin, at
408C. Presumably these red-colony formers became
homozygous for rpoAD305E as a result of recombination
between the chromosomal and plasmid rpoA alleles and
subsequent segregation. The details of the screen for
the recombinants and the tests confirming the exchange
are described in the Experimental procedures. When
this new rpoAD305E-containing plasmid, isolated from
these red colonies and named pNO2530* , is transformed
into the rpoA+ strain K1953, the nusE71 defect is sup-
pressed (there is effective gal operon expression as evi-
denced by formation of red colonies), indicating the
trans-dominant nature of the suppressor rpoAD305E
mutation in multicopy.
Locating the rpoAD305E mutation to the rpoA gene
The rpoA insert in pNO2530 is located immediately
downstream of the lac promoter (plac). To determine
whether rpoAD305E was an allele of rpoA, we subcloned
DNA fragments from pNO2530 and pNO2530* and placed
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Fig. 2. Fusion for selecting the rpoAD305E mutation and for
assessing levels of suppression of nus mutations (after Ward et al.
(1983)). The bacterium is a derivative of E. coli K-12 in which the
bacterial galactose operon (gal ) is fused to the pL promoter of a
defective l prophage. The essential components of this abbreviated
prophage are: a c I mutation eliminating repressor, the pL promoter,
the nutL signal, the N gene, and transcription terminators, including
a strong termination signal in an IS2 positioned immediately 5 ' of
the structural genes of the gal operon. In a nus7 derivative,
N-modified transcription antitermination is not functional and
therefore there is no gal expression (Gal7). Bacteria with
second-site mutations that suppress the nusE71 mutation were
selected as Gal+ mutants.
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them in the appropriate orientation for expression, down-
stream of the tac promoter (ptac) in a derivative of plasmid
pKK223-3 (de Boer, 1984), as shown diagrammatically in
Fig. 3. The resulting plasmids were tested for suppression
of the nusE71 mutation. Plasmid pKKrpoA* , which
includes the complete rpoA gene and the 5 ' two-thirds of
rplQ from pNO2530* , suppresses the nusE71 mutation,
whereas the same region from pNO2530 did not. Another
plasmid, which includes only the 3 ' end of rpoA as well as
the 5 ' two-thirds of rplQ from pNO2530* (our unpublished
results), fails to suppress the nusE71 mutation. Thus, we
conclude that rpoAD305E is indeed an allele of rpoA.
Sequencing the rpoAD305E mutation
Comparison of the DNA sequences of the rpoA genes in
pNO2530 and pNO2530* revealed a single nucleotide dif-
ference. The former has GAC at codon position 305 as
does the published sequence (Meek and Hayward, 1994),
while the latter has GAA at that codon position. The derived
amino acid sequence for the mutant a subunit has a glut-
amic acid at position 305 instead of aspartic acid encoded
in the wild-type a subunit at that position; we have
sequenced the entire fragment that expresses suppressor
activity and find this to be the only change from the wild-
type sequence. Additionally, sequencing of the mutant chro-
mosomal allele reveals the same change. Therefore, we
conclude that the change from an aspartic to a glutamic
acid at amino acid position 305 is responsible for the
rpoAD305E Nus-suppressor phenotype.
Suppression of other nus mutations
To characterize the range of suppression by the rpoAD305E
mutation, we assessed the effect of rpoAD305E on the
Nus7 phenotypes imposed by mutations in other nus
genes. Derivatives of strain K37, each carrying the
rpoAD305E mutation in addition to one of the nus muta-
tions, were tested for their ability to support l growth at
high temperatures using efficiency of plating (EOP) as
the assay for l growth (Table 1).
Results of this assay show that the rpoAD305E mutation
suppresses the Nus7 phenotypes imposed by all three
nus mutations. In this and other assays testing Nus activ-
ity, different temperatures were used in assessing the
Nus7 phenotype: 408C for those with nusB5 or nusE71
mutations, and 428C for those with the nusA1 mutation
(Friedman et al., 1984a). The two temperatures were
used because the nusA1 mutation is not restrictive for N
action at temperatures under 428C and the nusB5 and
nusE71 mutations are not suppressed efficiently by
rpoAD305E at 428C. Under these specific conditions,
derivatives of K37 (rpoA+) carrying the respective nus
mutations fail to support l growth. The EOP in each
case was <1075. The presence of rpoAD305E in any
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Fig. 3. Derivatives of pKK223-3 (Brosius and
Holy, 1984) with cloned rpoA genes. The
circles show the cloning vector, and the
diagrams above show the nature of the
cloned fragment in each construct. rrnB T1T2
are terminators from the rrnB operon. The
position of the ampr gene is indicated. The
cloned rpoA genes are oriented so that they
are expressed from the ptac promoter. On the
left is shown the extent of the fragment cloned
in both pKKrpoA and pKKrpoA* , and on the
right is shown the extent of the fragment
cloned in pKKrpoAD3 '. The region of
pKK223-3 between the SphI and PvuII sites
was deleted in all of these plasmids.
Table 1. Suppression of nus mutations by rpoAD305E, as measured
by EOP of k.
Strain
Temperature
(8C) Relevant genotype EOPa
Plaque
size
K4069 40 rpoAD305E 0.7 Large
K556 40 nusE71 <1075
K8248 40 nusE71 rpoAD305E 0.7 Small
K95 42 nusA1 <1075
K4047 42 nusA1 rpoAD305E 0.7 Tiny
K450 40 nusB5 <1075
K4070 40 nusB5 rpoAD305E 0.7 Very tiny
a. EOP is the efficiency of plating. This number is derived from phage
titres obtained at the indicated temperatures. EOP is the ratio of the
titre on a lawn of the strain with the mutant genotype divided by the
titre on a lawn of the parent E. coli ‘wild-type’ strain at the locus
being tested. lcI60 was used in this experiment.
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one of these nus-mutant strains results in an increase of
the EOP to nearly 1.
We next employed a more direct assay to assess the
degree of suppression by the rpoAD305E mutation. Sup-
pression was quantitatively assessed using bacterial
derivatives with the previously described pL–gal fusion
(Fig. 2). As shown in Table 2, hosts carrying any one of
the three nus mutations (nusA1, nusB5, or nusE71)
express galK levels that are ~10% of that observed in
the K1947 nus+ control. In the double rpoAD305E nus
mutants, galK expression was significantly higher, varying
from 30–100% of that observed in the nus+ control.
Although there were differences in the level of suppres-
sion, the essential point is that the results of this test,
similiar to those from the phage plating, show that
rpoAD305E suppresses the Nus7 phenotype of the
three nus mutations.
Suppression by a truncated rpoA gene
In vitro studies on the action of transcription activators
have shown that RNA polymerase with an a subunit
deleted at the carboxy terminus duplicates the effects of
point mutations that change specific amino acids in the
carboxy terminus of a (Ishihama, 1992). To determine if
there was a similar effect on suppression of nus mutations,
we examined whether the truncated a subunit, expressed
from an rpoA gene deleted for its 3 ' domain, affects the
Nus7 phenotype of E. coli derivatives with nus
mutations. E. coli strains haploid for an rpoA 3 ' deletion
are not viable, but plasmids expressing the truncated
rpoA can be maintained in strains that are wild type for
rpoA (Hayward et al., 1991). Based on these findings
and our observation that plasmids expressing the
rpoAD305E allele are trans-dominant, we postulated that
a 3' deletion of rpoA might suppress the Nus7 phenotype.
This hypothesis was tested using a plasmid expressing
the 3 '-deleted rpoA gene. Three plasmids, pKKrpoA,
pKKrpoA* , and pKKrpoAD3 ' (see Fig. 3), were tested in
parallel for suppression of nus mutations.
Sequence analysis predicts that pKKrpoAD3 ' should
express an a subunit that is truncated at amino acid 229
where an additional 15 amino acids encoded by the
vector sequence are added. Western blot analysis, using
an anti-a monoclonal antibody, identified a protein corre-
sponding to the size predicted for the truncated polypep-
tide in bacteria carrying pKKrpoAD3 '. This protein is not
seen in control bacteria that do not contain the plasmid
(data not shown).
The suppressor activity of the plasmid-based rpoA
alleles was examined by assessing the effects on l
growth as measured by EOP. As shown in Table 3, the
rpoAD3 ' allele, like the rpoAD305E allele, suppresses
the Nus7 phenotype of both the nusE71 and nusA1 muta-
tions. In contrast, when the wild type rpoA allele is
expressed from a plasmid constructed from the same
vector, neither nus mutation is suppressed. Although
these results clearly demonstrate that the two mutant
rpoA alleles suppress the Nus7 phenotype, interpretation
of the quantitative results is complicated by the necessity
of having a wild-type rpoA allele for viability. Therefore,
the finding that the increase in EOP effected by either
the plasmid-based rpoAD305E or rpoAD3 ' allele is lower
in the nusA1 mutant than in the nusE71 mutant could sug-
gest a difference in suppression, but also could result from
complications owing to the presence of the wild-type rpoA
allele. The pattern of suppression of the nusB5 mutation is
qualitatively different. By this test the rpoAD3 ' mutation,
similar to the wild-type allele, fails to suppress the nusB5
mutation, while the rpoAD305E allele does so weakly.
We emphasize the essential finding from these experi-
ments that the rpoAD3 ' allele, like the rpoAD305E allele,
suppresses the Nus7 phenotype of some nus mutations,
while pointing out the difficulty in assessing the signifi-
cance of the quantitative data because of the possibility
of interference with suppression by the wild-type rpoA
allele.
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Table 2. Suppression of nus mutations by rpoAD305E as measured
from a pL–nut- t–gal fusion in the presence of Na.
Percent Readthroughb
nus allele in strain Temperature (8C) rpoA+ rpoAD305E
nus+ 40 100 100
nusA1 42 13 104
nusE71 40 10 48
nusB5 40 7 27
a. See Fig. 2 for details on the pL–gal construct.
b. Percent readthrough equals (GalK level expressed from the fusion
in the mutant strain divided by the GalK expressed from the fusion in
the parent strain (wild type for relevant markers))6100. GalK levels
were measured as indicated in the Experimental procedures.
Table 3. Suppression of nus mutations by plasmid-based rpoA











K95 42 nusA1 Wild type <1075
K7565 42 nusA1 rpoAD305E 0.08
K7625 42 nusA1 rpoAD3 ' 0.02
K450 40 nusB5 Wild type <1075
K7568 40 nusB5 rpoAD305E 0.05
K7626 40 nusB5 rpoAD3 ' <1075
K556 40 nusE71 Wild type <1075
K7571 40 nusE71 rpoAD305E 0.8
K7627 40 nusE71 rpoAD3 ' 0.8
a. For details of EOP see Table 1. lcI60 was used in this
experiment.
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Effect on transcription initiation and termination
Studies presented in the previous sections show that rpoA
mutations can suppress the effect of mutations in three E.
coli genes whose products influence N-mediated tran-
scription antitermination. There are two ways to explain
this suppression by an rpoA mutation, either by an
increase in transcription initiation or by a decrease in tran-
scription termination. Therefore, we assessed the effect of
the rpoAD305E mutation on transcription initiation and ter-
mination in the absence of N. Beta-galactosidase levels
were compared between congenic rpoA+ and rpoAD305E
strains carrying a pL–N–lacZ protein fusion in a defective
prophage. There was essentially no difference between
the two strains with regard to promoter strength or N
expression, because each expressed ~2000 units of the
b-galactosidase fused to N. Termination was assessed
using three pKL600 derivatives that test the tR2 Rho-
independent or tR1 and tR3 Rho-dependent terminators
of phage l (Cheng et al., 1991; 1995; Patterson et al.,
1994). Because the transcription terminators are placed
upstream of the galK gene, expression of galK provides
a measure of termination. We found that the rpoAD305E
mutation did not have any significant effect on these termi-
nators (data not shown).
Effect of other rpoA alleles
We employed a l variant carrying the cro62 mutation to
screen other mutations in the carboxy terminus of rpoA
for this suppressor phenotype. The cro62 mutation results
from a deletion of a single base pair (bp) in the 3 ' terminus
of the l cro gene (Olson et al., 1982) that causes a shift in
the cro reading frame, resulting in translation extending
four nucleotides downstream of the usual UAA termination
codon to a UAA codon in the new reading frame. This
extension of translation moves the terminating ribosomes
closer to the 5 ' junction of NUT-R (three nucleotides away
instead of seven nucleotides away) and causes a failure in
N-mediated antitermination (Olson et al., 1982). Presum-
ably, the shift downstream of the terminating ribosomes
interferes with the assembly of the antitermination com-
plex at NUT-R (Olson et al., 1984). This defect in antitermi-
nation results in the failure of lcro62 to grow in K37 which
is wild type for nus alleles; however, lcro62 grows in
K4069, which is a K37 derivative carrying the
rpoAD305E mutation. lcro62 exhibits a four-log-greater
EOP on a lawn formed from K4069 than from a lawn
formed from K37 and also shows a similar high EOP on
a lawn formed from a K37 derivative carrying a plasmid
with the rpoAD3 ' allele.
We exploited our observation that the rpoAD305E
mutation converts E. coli from being non-permissive to
being permissive for lcro62 growth, to screen other
rpoA mutations for this suppressor phenotype. A number
of rpoA mutations constructed in E. coli C (Ayers et al.,
1994) were tested for their ability to enhance antitermi-
nation by examining lcro62 growth (Table 4). Two control
experiments confirmed that we could use this set of other-
wise isogenic mutants for this screen. First, lcro62 fails to
form plaques on a lawn formed from the parental E. coli C
strain containing the wild-type rpoA and, second, lcro62
forms plaques on a derivative of this E. coli C that carries
the rpoAD305E mutation.
Table 4 lists the seven rpoA E. coli C derivatives tested,
and specifies the amino acid change in the encoded a sub-
unit of each strain. This test identified only one other strain,
C4540, which had an rpoA mutation that suppresses the
antitermination defect. The rpoA mutation in this strain
results in a Leu to His change at amino acid position 290.
Discussion
The a subunit of E. coli RNA polymerase has been identi-
fied as the probable site for interaction of a number of tran-
scription factors (Ishihama, 1992; Russo and Silhavy,
1992; Ebright and Busby, 1995; Giladi et al., 1992). Muta-
tions influencing the action of such transcription factors
are usually found in non-overlapping clusters in the 3 '
region of the rpoA gene. Proteolytic treatment of the
329-amino-acid a subunit revealed that the carboxy term-
inal 85 amino acids form a domain (CTD) that dimerizes
and binds to DNA (Blatter et al., 1994). The CTD includes
the amino acids changed by the mutations that interfere
with the action of transcription activators. Clusters of muta-
tions are located at the following amino acid positions:
(i) 265–270, influencing the action of the cAMP-binding
protein at the lac P1 promoter (Zou et al., 1992);
(ii) 289–290, influencing the Ogr protein of phage P2
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Table 4. Effect of rpoA alleles on kcro62 growth.
Phage testedb
Straina Change in a subunit l lcro62
C1 None + 7
C4540 L290H + +
C4618 T323S + 7
C4622 P323L + 7
C4624 P322S + 7
C4630 K271E + 7
C4679 A272T + 7
C4680 E215K + 7
DC721 D305E + +
a. All strains, with one exception, are derivatives of the rpoA+ E. coli
C strain C1.
b. Phage growth was assessed by a spot test. A lawn of the indicated
bacterium was poured onto a Luria–Bertani (LB) plate. A dilution of l
sufficient to give single plaques was spotted onto the plate with the
seeded lawn. Plates were incubated at 378C. +, phage growth; 7,
no phage growth. l was lcI857 and lcro62 was lcI857cro62.
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(Ayers et al., 1994; Sunshine and Sauer, 1975); (iii) 311–
317, influencing the action of Fnr (an activator of anaerobi-
cally expressed genes) (Lombardo et al., 1991); and (iv)
322 or 323, influencing the action of OmpR and EnvZ
(which are regulators of porin expression) (Slauch et al.,
1991).
We have identified an rpoA mutation, rpoAD305E, that
changes amino acid 305 in the CTD of a. This altered a
subunit suppresses a variety of mutations, including
those in nus genes, that reduce the effectiveness of the
N-mediated transcription antitermination system of
phage l. A screen of seven other rpoA mutations that
alter the a CTD and affect transcription-initiation factors
(Ayers et al., 1994) identified one additional mutation
that exhibits suppression of a defect in N-mediated antiter-
mination. This mutation, rpoA109, changes amino acid
290 of the a subunit and was originally identified because
it interferes with the action of the phage-encoded Ogr tran-
scription-activation protein (Sunshine and Sauer, 1975).
Those changes in the CTD of a that had no effect on
N-mediated antitermination altered amino acids are at
positions 215, 271, 272, 322, and 323. These mutations
are all thought to affect transcription initiation, while the
rpoAD305E mutation influences transcription elongation.
Moreover, selections that yielded rpoA mutations that
affect the actions of other transcription factors have not
yielded, to our knowledge, any mutations in codon 305.
Thus, amino acid position 305 appears to have specificity,
in this case, for an interaction influencing transcription
elongation. Preliminary studies suggest that rpoAD305E,
unlike rpoA109 (L290H ), does not affect P2 Ogr function
(G. Christie, personal communication). Thus, there appears
to be overlap, but not identity, of amino acid patches used
by the Ogr initiation activator of P2 and the N antitermi-
nation system of l.
RNA polymerase reconstituted with an a subunit trun-
cated in its CTD also fails to interact with, and is not stimu-
lated by, activator proteins (Ishihama, 1992). This led to
the idea that the point mutations cause changes in the a
subunit that block interaction with the activators. To deter-
mine if something similar is occurring with rpoAD305E, we
examined the effect of a 3 '-truncated rpoA gene on N-
mediated antitermination and found that the truncated
gene product, like the product of the rpoAD305E allele,
suppresses the defect in antitermination caused by nus
mutations. These observations raise questions regarding
the nature of the interaction influenced by rpoAD305E. If
the results of only the experiments with rpoAD305E were
to be considered, a simple explanation for our obser-
vations would be that the rpoAD305E mutation enhances
the interaction of one, or more, of the components of the
N–Nus complex with RNA polymerase. Accordingly, this
enhanced interaction could compensate for an impaired
interaction of another component. The observation
that a variant a subunit missing its carboxy terminus
also suppresses some Nus7 phenotypes calls into ques-
tion enhanced interactions of the a CTD as the cause for
suppression by the rpoAD305E mutation. Because the
truncated a subunit is missing amino acids that include
amino acid 305, suppression cannot be mediated by facili-
tation of an interaction with amino acids at and near 305 in
the carboxy terminus, but, instead, it probably results from
a failure to interact with amino acids in this region. This
means that rpoAD305E is not sui generis, but, like the
other rpoA mutations, is affecting regulatory activity by
blocking an interaction with the a subunit. We suggest
that antitermination is restored for one of two reasons:
either rpoAD305E and rpoAD3 ' reduce transcription ter-
mination or they enhance antitermination. Our experi-
ments with tester systems designed to measure terminator
activity appear to rule out the first explanation, because
the rpoAD305E mutation has no effect on several l tran-
scription terminators in the absence of N.
We therefore favour the latter explanation, namely that
the rpoA mutations stimulate antitermination. This stimula-
tion is unlikely to be caused by overexpression of N or any
of the Nus factors. First, overexpression of N, NusA,
NusE, or NusG fails to duplicate the suppressive effects
observed with the rpoAD305E mutation (our unpublished
results). Second, the rpoAD305E mutation partially sup-
presses a nusB null mutation for l growth (M. Neeley, D.
Court, and D. Friedman, unpublished), showing that
NusB is not necessary for the suppression activity of
rpoAD305E.
Models explaining how mutations in the a subunit
enhance impaired N-mediated transcription elongation
would necessarily depend on interactions of a that might
occur either at initiation or during elongation of transcrip-
tion. The former would involve DNA and/or proteins at
the promoter in a manner similar to interactions previously
described for transcription activators, while the latter
would involve interactions downstream of the promoter
with the RNA, DNA, and/or a protein(s) composing the
antitermination complex. Regardless of the site of the
interaction, under conditions of impaired N action, the
final signal to RNA polymerase must result in a failure in
N-mediated antitermination that can be relieved by muta-
tions in rpoA. Although we have shown that transcription
levels from the l pL promoter are not affected by the
rpoAD305E mutation, this does not rule out the possibility
that a activity at the pL promoter affects transcription anti-
termination, but in an indirect manner.
As opposed to action at the promoter with a subsequent
effect on elongation, a could affect the elongation process
per se. For example, an interaction between a and the
DNA, similar to that observed at the rrn promoter (Ross
et al., 1993) but in this case during elongation, might
render polymerase less susceptible to modification by N
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and Nus factors. Alternatively, an interaction between a
and the NUT RNA might hinder formation of the antitermi-
nation complex directly, either by interfering with complex
formation or by facilitating action of an inhibitor of N-
mediated antitermination-complex formation. Liu and
Hannah (1995) have shown that, in vitro, the a CTD inter-
acts with the nascent RNA during transcription and this
interaction is not observed in the presence of NusA. We
have proposed an inhibitor to explain the results of our
genetic and physiological studies (Patterson et al.,
1994), and an inhibitor was also suggested to explain
NusB-independence for processive N-mediated antitermi-
nation in vitro with purified protein components (DeVito
and Das, 1994). The inhibitor could conceivably prevent
antitermination, in part, by interacting with the a subunit
of RNA polymerase. According to this model, the suppres-
sion observed with rpoAD305E and rpoAD3 ' mutations
(and presumably rpoAL290H) results from a reduction in
the interaction between a and the inhibitor. This loss of
inhibitor action, in turn, would permit a more unencum-
bered assembly of the N antitermination complex. Under
conditions where all components are functioning effec-
tively, the action of the inhibitor would be effectively
blocked. However, under conditions less optimal for for-
mation of antitermination complexes (e.g., in the presence
of nus mutations), the presence of the inhibitor would inter-
fere with complex formation, leading to a failure in antiter-
mination. Thus, loss of the inhibitor activity would allow for
effective complex formation under the suboptimal condi-
tions and result in effective antitermination.
We are unable to propose a definitive model to explain
how the rpoAD305E and rpoAD3 ' mutations suppress the
inhibitory effect on l growth caused by the cro62 frameshift
mutation, i.e., why lcro62 fails to grow in a nus+ host, K37,
but grows in a derivative of K37 that carries copies of either
the rpoAD305E or rpoAD3 ' alleles. However, we offer the
following hypothesis to explain this observation. The
cro62 frameshift results in an incursion of translating ribo-
somes into the NUT region (Olson et al., 1984) that
appears to compete with the efficient entry of N and/or
Nus factors to the NUT site. We suspect that the enhance-
ment of N action mediated by the amutations tilts this com-
petition in favour of N and thus allows growth of lcro62.
In vitro studies by Liu et al. (1996) found that RNA poly-
merase containing a subunits missing the carboxy term-
inal domain can be modified by N and Nus factors into
effective antitermination complexes. This indicates that
the carboxy terminus of a is not required to assemble
the antitermination complex and is consistent with the
arguments we have advanced regarding the requirement
for the carboxy terminal domain of the a subunit and the
putative inhibitory factor.
A role for an inhibitor of transcription elongation has
been described in humans. A 213-amino-acid protein
encoded by the VHL tumour-suppressor gene has been
proposed to modulate transcription by inhibiting action of
the SIII transcription-elongation factor (Latif et al., 1993;
Duan et al., 1995). Interestingly, it has been pointed out
that portions of the p15 subunit of SIII share sequence
similarity with the E. coli NusB and Rho transcription-
elongation proteins (Garrett et al., 1994).
In summary, we have presented evidence showing
that an interaction that promotes transcription elongation
appears to be regulated through interactions with the a
subunit of RNA polymerase. As many other studies have
identified a role for the a subunit in initiation of transcrip-
tion, our studies identify an expanded role for this subunit
in the transcription-elongation process.
Experimental procedures
Bacteria
Relevant genotypes and sources of bacteria used in these
studies are listed in Table 5.
Media
The media used in these experiments have been described
previously (Miller and Friedman, 1980).
Plasmids
pNO2530, pNO2341, pNO2685, and pNO2695 were supplied
by M. Nomura (Cerretti et al., 1983). pNO2530* was obtained
by recombining the rpoAD305E mutation from the chromo-
some with pNO2530. pKKrpoA (Fig. 3) was constructed by
isolating a 1318 bp HindIII–NruI fragment, which contained
all of rpoA and a 5 ' portion of the adjacent rplQ gene from
pNO2530, and ligating it into the HindIII site of pKK223-3
(Brosius and Holy, 1984). The resulting plasmid was deleted
of 1503 nucleotides of pKK223-3 located between the SphI
and PvuII sites. The identical procedure was followed to
construct pKKrpoA* , except that pNO2530* was used as
the donor of the HindIII–NruI fragment. pKKrpoAD3 ' was
constructed by cloning the 711 bp HindIII fragment from
pNO2530, containing a truncated rpoA gene deleted of its
3 '-terminal 300 nucleotides, into the HindIII site of pKK223-
3 (also deleted for the 1503 nucleotides between the
SphI and PvuII sites). pKL600, supplied by K. McKenney,
is a terminator-tester plasmid that has a polycloning site
between plac and a galK reporter gene (McKenney et al.,
1981). pKLtR2 and pKLtR3 are derivatives of pKL600 that
have the tR2 (Rho-independent) or tR3 (Rho-dependent) ter-
minators, respectively, of l cloned in the proper orientation in
the polycloning site (Cheng et al., 1991; 1995).
Phage and source
lcI60 and lcI857 were obtained from the NIH collection;
lcI857cro62 is from these laboratories.
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Phage techniques
Efficiency of phage plating (EOP) was determined as described
previously (Friedman et al., 1984b). Dilution spot tests used to
obtain a semi-quantitative evaluation of phage growth were
performed by spotting drops of serial dilutions of phage on
lawns formed from the indicated bacterium and scoring
growth according to the dilutions that showed phage growth.
Nucleic acid and protein procedures
DNA preparation, restriction enzyme digestions, ligations,
and transformations were performed essentially as described
by Sambrook et al. (1989). Protein purification and two-
dimensional electrophoresis of ribosomal proteins have pre-
viously been described (Friedman et al., 1981). Western
analysis was performed as previously described (Craven
et al., 1994).
DNA sequencing
Sequenase version 2.0 dideoxy sequencing system (United
States Biochemical) was employed using an [a-35S]-dATP
(Amersham) label. Derivatives of M13mp18 or M13mp19
(Yanisch-Perron et al., 1985) carrying the desired cloned
fragments served as single-stranded DNA templates for
sequencing. The sequencing reactions were run on a six or
eight percent polyacrylamide gel for varying lengths of time.
Both strands of the DNA were sequenced.
Galactokinase assay
Enzyme levels were measured according to the published
method (Adhya and Miller, 1979).
Beta-galactosidase assay
Enzyme levels were measured according to Miller (1992).
Genetic techniques
P1 transduction and Hfr crosses were performed in the stan-
dard manner (Miller, 1972; Sternberg and Maurer, 1991).
Selection for second-site suppressors of nusE71
This scheme, devised by Ward et al. (1983), uses derivatives
of an E. coli K-12 strain, K1947, that has a fusion of the bac-
terial gal operon to the pL promoter of a defective l prophage.
The abbreviated prophage also has the associated nutL
signal, N gene, and a defective c I allele (Fig. 2). Additionally,
there are at least two transcription-termination signals located
between pL–nut and the gal operon. One of the terminators is
located in an IS2 positioned in the leader region of the gal
operon. This Rho-dependent terminator is very efficient
and, therefore, in this construct, transcription initiating at
pgal should terminate upstream of the gal genes. However,
the prophage in K1947 does not express an active repressor
and constitutively expresses N from the pL promoter. The
expressed N, in turn, modifies the RNA polymerase transcrib-
ing the pL operon, allowing transcription to transcend all
downstream terminators and read into the gal operon, produc-
ing a Gal+ phenotype.
In our adaptation of the selection, a derivative of K1947,
K1953, carries the nusE71 mutation, causing N to be ineffec-
tive. Hence, the bacterium is Gal7 even though N expression
is constitutive. Suppressors of the Nus7 phenotype should
result in the bacteria being Gal+ because N action would be
supported. Gal+ colonies were obtained (at a frequency of
~1078) and ~80% of these supported l growth and, therefore,
supported N action more effectively than did the starting par-
ental recipient. We attempted to limit the mutant search to the
72 min region of the E. coli chromosome which has a large
number of genes encoding ribosomal proteins (Nomura
et al., 1977). Localized mutagenesis (Hong and Ames,
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Table 5. Bacterial strains used in this study.
Strain
Parent
strain Relevant genotype Source
AB1133 thr1 leu6 thi1 supE44 lacY1
galK2 ara14 xyl5 mtl1
proA2 his4 argE3 str31
sipA1
L. S. Baron
K37 galK, StrR This laboratory
K450 K37 nusB5 This laboratory
K556 K37 nusE71 This laboratory
K1947 N5261 gal490* (chl–blu)del8 Bamdel
N + cI14 H1del
M. Gottesman
K1953 K1947 gal490* (chl–blu)del8 Bamdel
N + cI14 H1del nusE71
zhb-3082::Tn10
This work
K2090 K1953 gal490* (chl–blu)del8 Bamdel




K4069 K37 rpoAD305E This work
K6325 K2090 gal490* (chl–blu)del8 Bamdel




K6953 AB1133 nusA1 rpoAD305E This work
K6995 K6953 K6953 + pNO2530 This work
K7004 K6953 K6953 + pNO2530* This work
K7005 K1953 K1953 + pNO2530* This work
K7006 K1953 K1953 + pNO2530 This work
K4047 K4069 nusA1 rpoAD305E This work
K4090 K4069 nusB5 rpoAD305E This work
K7257 K37 K37 + pKKrpoA This work
K7254 K37 K37 + pKKrpoA* This work
K7258 K37 K37 + pKKrpoAD3 ' This work
K4195 AB1133 nusA1 rpoAD305E nusE71
zhb-3082::Tn10
This work
K8248 K37 nusE71 rpoAD305E
zhb-3082::Tn10
This work
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1971) was employed using hydroxylamine treatment of a P1
lysate grown on a nusE71 host, K2016. This bacterium has
a Tn10 insertion (Kleckner et al., 1991) (zhb-3082::Tn10, con-
ferring resistance to tetracycline (TetR)) linked to the 72 min
region (Singer et al., 1989). Because P1 transducing particles
can package 100 kb (2%) of the E. coli chromosome (Stern-
berg and Maurer, 1991), it was expected that by using this
lysate to transduce for TetR, we would enrich for mutations
in the 72 min region. Second-site suppressors were distin-
guished from true revertants using two-dimensional gel elec-
trophoresis to determine if the S10 protein maintained the
altered mobility caused by the nusE71 mutation (Friedman
et al., 1981). One mutant, K2090, identified as having a
second-site suppressor, was chosen for further characteriza-
tion. The second-site mutation, rpoAD305E, was located to
the 72 min region of the E. coli genetic map by cotransduction
with zhb-3082::Tn10. As the predominant change caused by
hydroxylamine mutagenesis is C to T (Budowsky, 1976), we
assume that the rpoAD305E mutation did not result from
the hydroxylamine treatment but, instead, from a sponta-
neous mutation. The selection of an apparent spontaneous
mutation following in vitro hydroxylamine mutagenesis of
phage is not without precedent (Min Jou et al., 1972).
Marker rescue of rpoAD305E
K6325 (a derivative of K2090 with a substitution of a kanr
marker for the tet r marker of zhb-3082::Tn10) carrying
pNO2530 was employed to transfer the rpoAD305E mutation
to the plasmid by recombination between the chromosome
and the cloned genes of the plasmid. Colonies containing
such candidate recombinant plasmids were identified on
MacConkey–galactose plates that contained ampicillin
(30mg ml71) to maintain selective pressure for the plasmids.
The starting strain has the rpoA+ allele on the plasmid and
the rpoAD305E mutation on the chromosome. Because of
partial dominance of rpoAD305E, K6325 with pNO2530 forms
pink colonies on these indicator plates, unlike K6325, which
forms dark-red colonies. However, dark-red colonies were
occasionally observed (~1/100) when K6325 harbouring
pNO2530 was plated on MacConkey–galactose–ampicillin
plates. When these colonies were restreaked on the indicator
plates containing ampicillin, dark-red colonies could be iso-
lated. These bacteria obviously expressed higher levels of
gal enzymes than those forming the pink colonies. We
assumed that the rpoAD305E allele had recombined from
the chromosome to the plasmid and the bacteria had
become homogenotized for the mutant allele.
Plasmid DNA was isolated from a dark-red colony and this
plasmid, named pNO2530* , was shown to have an insert that
was seemingly identical to pNO2530. However, unlike
pNO2530, pNO2530* suppressed the Nus7 phenotype; when
pNO2530* was transformed into the nusE71 parent strain,
K1953, dark-red colonies were formed on MacConkey–galac-
tose plates. The suppressor activity of pNO2530* was also
assessed by phage plating. At 408C, l will not form plaques
on a lawn of K1953, because N-mediated antitermination
is inoperative. l also fails to form plaques on a lawn of
a derivative of K1953 carrying pNO2530, but does form
plaques on a lawn of a derivative of K1953 carrying
pNO2530* (data not shown). These results lead us to
conclude that the rpoAD305E mutation had recombined
from the chromosome to the plasmid, and that pNO2530*
carries the rpoAD305E mutation.
Crossing rpoAD305E away from nusE71
A triple nusA1 nusE71 rpoAD305E mutant is thermosensi-
tive, growing only at temperatures below 428C. Previous
studies had shown that a nusA1 nusE71 double mutant grows
at 428C but fails to support growth of N-dependent l phage
(Friedman et al., 1983). Thus, if the rpoAD305E mutation sup-
presses the Nus7 phenotype imposed by the nusA1 mutation,
we suspected that it would be possible to select and screen for
a nusA1 rpoAD305E double mutant following P1 transduction
from the nusE71 rpoAD305E zhb-3082::Tn10 donor to a
nusA1 recipient. This could be accomplished by selecting
for TetR colonies at 428C and screening the survivors for
their Nus phenotype. Because nusE71, rpoAD305E, and
zhb-3082::Tn10 are linked, one expected class of recombi-
nants, triple nusA1 nusE71 rpoAD305E mutants, should be
selected against by growing at the high temperature. Surviv-
ing bacteria that do not have rpoAD305E, but carry nusA1
only, or nusA1 and nusE71, should not support l growth at
428C. We expected that the nusA1 rpoAD305E double
mutant might grow and support l growth at 428C. Recombi-
nant progeny of such a cross were obtained at 428C and
screened for support of l growth at 428C; 4% of the TetR bac-
teria had this phenotype. One such recombinant, K4047, was
chosen for further study. Genetic outcrosses confirmed that
this recombinant contains the nusA1 and rpoAD305E muta-
tions (data not shown).
A nus+ recombinant, K4069, that has the rpoAD305E
mutation free of any nus mutations was constructed by P1
transduction using K4047, the nusA1 rpoAD305E strain, as
the donor. The recipient was the K37 nus+ strain and the
selective marker was the zhb-3082::Tn10 located near
rpoAD305E. We could not ascribe any phenotype to the
rpoAD305E mutation per se; therefore, potential rpoAD305E
and zhb-3082::Tn10 recombinants were backcrossed to the
nusA1 mutant, K95. Because the Tn10 is near rpoA, we
assumed that if a donor harboured the rpoAD305E mutation
then some of the TetR recombinants generated in the back-
cross would also acquire the rpoAD305E mutation. When
one TetR K37 derivative, K4069, was the donor in the back-
cross to K95, 14/30 TetR transductants scored as having
suppressors of the Nus7 phenotype, demonstrating that the
donor K4069 strain contains the rpoAD305E allele.
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